Latest Ratings for CRSP
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | RBC Capital | Maintains | Sector Perform | |
| Feb 2022 | SVB Leerink | Maintains | Outperform | |
| Dec 2021 | Cowen & Co. | Initiates Coverage On | Market Perform |
These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results
